idw – Informationsdienst Wissenschaft
Nachrichten, Termine, Experten
Nachrichten, Termine, Experten
idw - Informationsdienst
Wissenschaft
A recent study carried out by a research team from the Paul-Ehrlich-Institut investigated the immunomodulating properties of β-glucans. These are natural sugar compounds found in bacteria, fungi and grains. The results indicate that β-glucans can target the immune system and modulate pro-inflammatory responses. Their potential to suppress allergic reactions and offer new approaches to allergy treatment is particularly promising. The scientific publication has been published in the International Journal of Molecular Sciences.
β-glucans are natural sugar compounds found in bacteria, fungi and grains. They act on specific receptors in the immune system and can thereby trigger different reactions. As a result, they can promote the activity of immune cells that are responsible for fighting pathogens and modulate inflammatory processes, among other activities. Their potential as an adjuvant is particularly promising. One use for adjuvants is as a vaccine ingredient to strengthen the immune response and thus strengthen vaccination protection.
Adjuvants in Allergology
Adjuvants are also used for therapeutic allergens, which assist in influencing (modulating) the immune system in a way that contributes to reducing the allergic reactions and to helping the patient adapt to the allergen.
Allergen-specific immunotherapy involves researching adjuvants in order to modulate allergen-specific (known as Th2) immune reactions in a targeted manner and to re-establish tolerance toward certain allergens.
A research group led by PD Dr Stefan Schülke, head of the Research Allergology Division at the Paul-Ehrlich-Institut conducted a study to test six different β-glucans, including zymosan and its variants, as well as other known β-1,3 glucans for their influence on the immune system. The group found that these substances activate different immune cells and influence the release of certain pro-inflammatory substances in different ways. Zymosan and β-1,3 glucan in particular were able to reduce the production of inflammatory markers in the experiments and showed a promising ability to suppress allergy-related immune responses.
The results of the study are promising and could help to develop new therapeutic approaches for the treatment of allergies. In the future, β-glucans could play an important role in preventing allergic reactions and controlling the immune response in a targeted manner.
Highlighted Results in Detail
The study analysed both immunological (receptor activation, cytokine secretion, T-cell modulation) and metabolic parameters (metabolic state) in dendritic cells – specific immune cells – derived from the bone marrow of mice. It was found that all of the β-glucans tested activated the C-type lectin receptor (CLR) Dectin-1a, while the "Toll"-like receptor 2 (TLR2) was particularly strongly triggered by zymosan. The β-glucans also led to different degrees of cytokine secretion and activation of cell metabolism in the dendritic cells.
A more detailed study of the β-glucans zymosan, β-1,3 glucan and β-1,3/1,6 glucan showed that these β-glucans increased the activation of the dendritic cells and upregulated the important surface markers CD40, CD80, CD86 and MHCII to varying degrees. Another finding: the cytokine secretion induced by β-glucans was partly dependent on the activation of the intracellular Dectin-1 adapter molecule Syk.
In co-cultures of dendritic cells with mouse T cells sensitised to the major birch pollen allergen Bet v 1, four of the β-glucans tested suppressed allergen-induced IL-5 secretion. However, only zymosan and β-1,3 glucan significantly reduced the secretion of interferon gamma (IFNγ). This suggests that the β-glucans tested have different impacts on the ability of dendritic cells to target T cells for allergens.
Rainer H, Goretzki A, Lin YJ, Schiller HR, Krause M, Döring S, Strecker D, Junker AC, Wolfheimer S, Toda M, Scheurer S, Schülke S (2024): Characterization of the Immune-Modulating Properties of Different β-Glucans on Myeloid Dendritic Cells.
Int J Mol Sci 25: 9914.
DOI: https://doi.org/10.3390/ijms25189914
https://www.mdpi.com/1422-0067/25/18/9914 - Full text (Open Access)
https://www.pei.de/EN/newsroom/press-releases/year/2025/02-beta-glucans-promisin... - This Press Release on the Website of the Paul-Ehrlich-Institut
Audio quote summary of the results
Merkmale dieser Pressemitteilung:
Journalisten, Wissenschaftler
Biologie, Medizin
überregional
Forschungsergebnisse, Wissenschaftliche Publikationen
Englisch
Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.
Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).
Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.
Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).
Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).
